| Released | Contributor | Author | Title | Pages | Price |
| 9-Feb-2010 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Market Research and Competitive Analysis 2010 | 730 |
$299 |
| 9-Feb-2010 | Plunkett Research, Ltd. | Jack W. Plunkett | Plunkett's Health Care Technologies Overview 2010 (Summary) | 80 |
$199 |
| 9-Feb-2010 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Trends, Statistics & Analysis 2010 (Summary) | 98 |
$199 |
| 9-Feb-2010 | New Constructs, LLC |
N/A
| TGX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 9-Feb-2010 | EconomicInvestor |
N/A
| "The Economy Matters" Report for TGX: the economy's impact on TGX's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 |
$15 |
| 8-Feb-2010 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for TGX | 13 |
$25 |
| 7-Feb-2010 | Wright Reports |
N/A
| Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) | 98 |
$169 |
| 6-Feb-2010 | Pechala's Reports | Frantisek Pechala | THERAGENICS CORP (TGX=US) 12-months forecast | 1 |
$15 |
| 6-Feb-2010 | PriceTarget Research, Inc. |
N/A
| S&P Small Cap Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. | 65 |
$40 |
| 6-Feb-2010 | PriceTarget Research, Inc. |
N/A
| S&P Super 1500 Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 25 new Laggards. | 65 |
$40 |
1.52% Nasdaq 
Research Reports
